Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krsnaa Diagnostics's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was ₹12.70.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was ₹30.86.
During the past 12 months, Krsnaa Diagnostics's average earnings per share (NRI) Growth Rate was 31.10% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 17.10% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 19.90% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Krsnaa Diagnostics's EPS without NRI or its related term are showing as below:
NSE:KRSNAA'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0.9 Med: 26.3 Max: 75.7
Current: 17.1
During the past 8 years, Krsnaa Diagnostics's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 75.70% per year. The lowest was 0.90% per year. And the median was 26.30% per year.
NSE:KRSNAA's 3-Year EPS without NRI Growth Rate is ranked better than 57.59% of 158
companies
in the Medical Diagnostics & Research industry
Industry Median: 10.75
vs NSE:KRSNAA: 17.10
Krsnaa Diagnostics's EPS (Basic) for the
three
months ended in Mar. 2026 was ₹12.86.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹31.31.
Krsnaa Diagnostics (NSE:KRSNAA) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Krsnaa Diagnostics EPS without NRI Related Terms
Krsnaa Diagnostics EPS without NRI Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:KRSNAA vs TMO, DHR, IDXX: EPS without NRI Comparison
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics PE Ratio without NRI vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹30.86
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krsnaa Diagnostics (NSE:KRSNAA) has a EPS without NRI of ₹30.86 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Krsnaa Diagnostics and its competitors. According to the industry distribution chart, Krsnaa Diagnostics ranks #67 out of 158 companies in the Medical Diagnostics & Research industry, placing it in the top 42.4%.
Is Krsnaa Diagnostics' EPS without NRI too high?
Krsnaa Diagnostics' current EPS without NRI is ₹30.86. Based on the distribution chart, Krsnaa Diagnostics ranks #67 out of 158 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Krsnaa Diagnostics has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #67 out of 158 companies for EPS without NRI. This puts Krsnaa Diagnostics in the upper half of its industry. The industry median EPS without NRI is 10.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.75, based on 158 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Krsnaa Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current EPS without NRI is ₹30.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹920.33, compared to a current price of ₹544.80 — trading 40.8% below its estimated fair value. The current EPS without NRI is ₹30.86. Krsnaa Diagnostics' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current EPS without NRI is ₹30.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹544.80 is trading 40.8% below its estimated GF Value™ of ₹920.33.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
EPS without NRI: ₹30.86
GF Value™: ₹920.33 vs. price of ₹544.80 (40.8% below fair value)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
67GF Score
Get the complete analysis for NSE:KRSNAA
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
